Premium
Neuroleptic Malignant Syndrome in Alzheimer's Disease
Author(s) -
Serby Michael
Publication year - 1986
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1986.tb07266.x
Subject(s) - medicine , disease , neuroleptic malignant syndrome , psychiatry , documentation , intensive care medicine , alzheimer's disease , pediatrics , gerontology , pathology , computer science , programming language
Neuroleptic malignant syndrome (NMS) has been the subject of discussion in a number of recent literature reviews 1,2 ; a natural outcome due to the increasing awareness of this potentially lethal disorder. Reviews and case reports suggest that youth is a predisposing factor 1,2 ; there is no case report over 61 years of age. Although organic brain syndrome is cited as a risk factor, there is no documentation to support this. Recently, I treated an episode of NMS in a 65 year old man with Alzheimer's disease (AD). This case brought into focus certain issues relevant to the management of patients with AD.